Evidence map›Paper›PMID 34660548›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Visible Light-Generated Antiviral Effect on Plasmonic Ag-TiO

Zsolt Boldogkői, Zsolt Csabai, Dóra Tombácz, László Janovák, Lilla Balassa, Ágota Deák, Péter S Tóth, Csaba Janáky, Ernő Duda, Imre Dékány

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zsolt BoldogkőiDepartment of Medical Biology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Zsolt CsabaiDepartment of Medical Biology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Dóra TombáczDepartment of Medical Biology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
László JanovákDepartment of Physical Chemistry and Materials Science, University of Szeged, Szeged, Hungary.
Lilla BalassaDepartment of Physical Chemistry and Materials Science, University of Szeged, Szeged, Hungary.
Ágota DeákDepartment of Physical Chemistry and Materials Science, University of Szeged, Szeged, Hungary.
Péter S TóthDepartment of Physical Chemistry and Materials Science, Interdisciplinary Excellence Centre, University of Szeged, Szeged, Hungary.
Csaba JanákyDepartment of Physical Chemistry and Materials Science, Interdisciplinary Excellence Centre, University of Szeged, Szeged, Hungary.
Ernő DudaDepartment of Medical Biology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Imre DékányDepartment of Physical Chemistry and Materials Science, University of Szeged, Szeged, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent coronavirus pandemic pointed out the vulnerability of humanity to new emerging infectious diseases. Experts warn that future pandemics may emerge more frequently with greater devastating effects on population health and the world economy. Although viruses are unable to propagate on lifeless surfaces, they can retain their infectivity and spread further on contact with these surfaces. The objective of our study is to analyze photoreactive composite films that exert antiviral effects upon illumination. Reactive plasmonic titanium dioxide-based polymeric nanocomposite film was prepared with a thickness of 1-1.5 µm, which produces reactive oxygen species (ROS) under visible light irradiation (

Indexed as

antiviral surfaceepidemic prevention and controlherpesvirusphotooxidationphotoreactive composite filmpseudorabies virus

Identifiers

PMID34660548
PMCPMC8513738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.